| dc.contributor.author | Aimé, Ahissan | |
| dc.contributor.author | Beztsinna, Nataliia | |
| dc.contributor.author | Patwa, Amit | |
| dc.contributor.author | Pokolenko, Alexander | |
| dc.contributor.author | Bestel, Isabelle | |
| dc.contributor.author | Barthélémy, Philippe | |
| dc.date.accessioned | 2019-06-14T05:00:52Z | |
| dc.date.available | 2019-06-14T05:00:52Z | |
| dc.date.issued | 2013-07-26 | |
| dc.identifier.issn | 1043-1802 (P-ISSN) | |
| dc.identifier.issn | 1520-4812 (E-ISSN) | |
| dc.identifier.uri | http://27.109.7.66:8080/xmlui/handle/123456789/580 | |
| dc.description | Bioconjugate Chemistry, Vol-24, Issue-8, 2013, p. 1345-1355 | en_US |
| dc.description.abstract | The construction of new nanotools is presented here using the example of fluorescent semiconductor nanocrystals, quantum dots (QDs). In this study, the implementation of the new lipid oligonucleotide conjugate-functionalized quantum dots (LON-QDs) is realized in four steps: (i) the synthesis of the lipid oligonucleotide conjugates (LONs), (ii) the encapsulation of QDs by nucleolipids and LONs, (iii) the study of the duplex formation of LON-QDs with the complementary ON partners, and (iv) the cellular uptake of the LON-QD platform and hybridization with the target ONs (microRNA and miR-21). | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | American Chemical Society | en_US |
| dc.subject | Quantum dots | en_US |
| dc.subject | Bioconjugates | en_US |
| dc.subject | Lipid-oligonucleotide | en_US |
| dc.subject | Self-assembly | en_US |
| dc.subject | Surface plasmon resonance | en_US |
| dc.title | Quantum dot lipid oligonucleotide bioconjugates: toward a new anti-microrna nanoplatform | en_US |
| dc.type | Article | en_US |